2016. BSG Conference – Indicators of Suboptimal Therapy Among Crohn’s Disease Patients Treated with Tumor Necrosis Factor Antagonists: Results from a Multi-National Study

Armuzzi A, Lindsay JO, Mody R, Bokemeyer B, Gisbert J, Peyrin-Biroulet L, Nguyen GC, Siebenaler J, Åkerborg Ö, Smyth M. Indicators of Suboptimal Therapy Among Crohn’s Disease Patients Treated with Tumor Necrosis Factor Antagonists: Results from a Multi-National Study. Gut 2016;65(suppl 1):A254. Presented at: BSG 2016 Conference; June 20-23, 2016; Liverpool, UK.